Does work on obsessive-compulsive spectrum disorders contribute to understanding the heterogeneity of obsessive-compulsive disorder?

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 3, 2006, Pages 353-361

  Lochner, Christine ^a   Stein, Dan J ^a,b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cluster analysis; Heterogeneity; Obsessive compulsive disorder; Obsessive compulsive spectrum disorder; Subtypes

Indexed keywords

ARTICLE; AUTOMATION; AUTOMUTILATION; BODY DYSMORPHIC DISORDER; CLUSTER ANALYSIS; EATING DISORDER; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERSEXUALITY; HYPOCHONDRIASIS; IMPULSIVENESS; INTERMITTENT EXPLOSIVE DISORDER; KLEPTOMANIA; MEDICAL LITERATURE; OBSESSIVE COMPULSIVE DISORDER; PATHOLOGICAL GAMBLING; SHOPPING; TRICHOTILLOMANIA;

CLUSTER ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FAMILY HEALTH; HUMANS; IMPULSE CONTROL DISORDERS; MEDLINE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; REWARD; SOMATOFORM DISORDERS;

EID: 33646042871     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.11.004     Document Type: Article

References (136)

1. Abramowitz J.S., Brigidi B.D., and Foa E.B. Health concerns in patients with obsessive-compulsive disorder. J Anxiety Disord 13 (1999) 529-539
2. Alsobrook II J.P., Leckman J.F., Goodman W.K., Rasmussen S.A., and Pauls D.L. Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet 88 (1999) 669-675
3. Alsobrook J.P., Zohar A.H., Leboyer M., Chabane N., Ebstein R.P., and Pauls D.L. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet 114 (2002) 116-120
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (1994), American Psychiatric Association, Washington, DC
5. Anton R.F. Obsessive-compulsive aspects of craving: development of the obsessive-compulsive drinking scale. Addiction 95 (2000) S211-S217
6. Barsky A.J. Hypochondriasis and obsessive-compulsive disorder. Psychiatr Clin North Am 15 (1992) 791-801
7. Bellodi L., Cavallini M.C., Bertelli S., Chiapparino D., Riboldi C., and Smeraldi E. Morbidity risk for obsessive-compulsive spectrum disorders in first-degree relatives of patients with eating disorders. Am J Psychiatry 158 (2001) 563-569
8. Bengel D., Greenberg B.D., Cora-Locatelli G., Altemus M., Heils A., Li Q., et al. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol Psychiatry 4 (1999) 463-466
9. Bergh C., Eklund T., Sodersten P., and Nordin C. Altered dopamine function in pathological gambling. Psychol Med 27 (1997) 473-475
10. Bienvenu O.J., Samuels J.F., Riddle M.A., Hoehn-Saric R., Liang K.Y., Cullen B.A., et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 48 (2000) 287-293
11. Black D.W., Goldstein R.B., Noyes Jr. R., and Blum N. Compulsive behaviours and obsessive-compulsive disorder (OCD): lack of a relationship between OCD, eating disorders, and gambling. Compr Psychiatry 35 (1994) 145-148
12. Blum K., Braverman E.R., Holder J.M., Lubar J.F., Monastra V.J., Miller D., et al. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoact Drugs 32 (2000) i-112 [Suppl]
13. Bolton D. Obsessive-compulsive disorder. In: Hersen M., and B.A. (Eds). Comprehensive clinical psychology (1998) 367-391 [San Francisko]
14. Camarena B., Rinetti G., Cruz C., Gomez A., de la Fuente J.R., and Nicolini H. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. Am J Med Genet 105 (2001) 279-282
15. Castellanos F.X., Ritchie G.F., Marsh W.L., and Rapoport J.L. DSM-IV stereotypic movement disorder: persistence of stereotypies of infancy in intellectually normal adolescents and adults. J Clin Psychiatry 57 (1996) 116-122
16. Catapano F., Sperandeo R., Perris F., Lanzaro M., and Maj M. Insight and resistance in patients with obsessive-compulsive disorder. Psychopathology 34 (2001) 62-68
17. Cavallini M.C., Di Bella D., Siliprandi F., Malchiodi F., and Bellodi L. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet 114 (2002) 347-353
18. Comings D.E., Wu S., Chiu C., Ring R.H., Gade R., Ahn C., et al. Polygenic inheritance of Tourette's syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the addictive and subtractive effect of the three dopaminergic genes-DRD2, DBH and DAT1. Am J Med Genet 67 (1996) 288
19. Como P.G. Obsessive-compulsive disorder in Tourette's syndrome. Adv Neurol 65 (1995) 281-291
20. Crino R.D., and Andrews G. Personality disorder in obsessive-compulsive disorder: a controlled study. J Psychiatr Res 30 (1996) 29-38
21. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch Neurol 50 (1993) 873-880
22. Cummings J.L., and Benson D.F. Psychological dysfunction accompanying subcortical dementias. Annu Rev Med 39 (1988) 53-61
23. Damecour C.L., and Charron M. Hoarding: a symptom, not a syndrome. J Clin Psychiatry 59 (1998) 267-272
24. Dannon P.N. Topiramate for the treatment of kleptomania: a case series and review of the literature. Clin Neuropharmacol 26 (2003) 1-4
25. Deltito J.A. Valproate pretreatment for the difficult-to-treat patient with OCD. J Clin Psychiatry 55 (1994) 500
26. Denckla M.B., and Rapoport J.L. Neurobiological examination. In: Denckla M.B., and Rapoport J.L. (Eds). Obsessive-compulsive disorder in children and adolescents (1989), American Psychiatric Press, Washington, DC
27. du Toit P.L., van Kradenburg J., Niehaus D., and Stein D.J. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview. Compr Psychiatry 42 (2001) 291-300
28. Ebstein R.P., Benjamin J., and Belmaker R.H. Personality and polymorphisms of genes involved in aminergic neurotransmission. Eur J Pharmacol 410 (2000) 205-214
29. Eisen J.L., Goodman W.K., Keller M.B., Warshaw M.G., DeMarco L.M., Luce D.D., et al. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry 60 (1999) 346-351
30. Eisen J.L., Rasmussen S.A., Phillips K.A., Price L.H., Davidson J., Lydiard R.B., et al. Insight and treatment outcome in obsessive-compulsive disorder. Compr Psychiatry 42 (2001) 494-497
31. Enoch M.A., Kaye W.H., Rotondo A., Greenberg B.D., Murphy D.L., and Goldman D. 5-HT2A promoter polymorphism-1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet 351 (1998) 1785-1786
32. Erzegovesi S., Cavallini M.C., Cavedini P., Diaferia G., Locatelli M., and Bellodi L. Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol 21 (2001) 488-492
33. Fallon B.A., Javitch J., and Liebowitz M.R. Hypochondriasis and OCD. Overlaps in diagnosis and treatment. J Clin Psychiatry 52 (1991) 457-460
34. Fallon B.A., Schneier F.R., Marshall R., Campeas R., Vermes D., Goetz D., et al. The pharmacotherapy of hypochondriasis. Psychopharm Bull 32 (1996) 607-611
35. Foa E.B. Failure in treating obsessive-compulsives. Behav Res Ther 17 (1979) 169-176
36. Foa E.B., Kozak M.J., Goodman W.K., Hollander E., Jenike M.A., and Rasmussen S.A. DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry 152 (1995) 90-96
37. Foa E.B., Abramowitz J.S., Franklin M.E., and Kozak M.J. Feared consequences, fixity of belief and treatment outcome in patients with obsessive-compulsive disorder. Behav Ther 30 (1999) 717-724
38. Freud S. Character and anal erotism. In: Strachey J. (Ed). Standard edition of the complete psychological works of Sigmund Freud (1908), Hogarth Press, London 169-175
39. Geller D., Biederman J., Jones J., Park K., Schwartz S., Shapiro S., et al. Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. J Am Acad Child Adolesc Psychiatry 37 (1998) 420-427
40. George M.S., Trimble M.R., Ring H.A., Sallee F.R., and Robertson M.M. Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's syndrome. Am J Psychiatry 150 (1993) 93-97
41. Giedd J.N., Rapoport J.L., Garvey M.A., Perlmutter S.J., and Swedo S.E. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry 157 (2000) 281-283
42. Goodman W.K., Ward C.H., Kablinger A., and Murphy T. Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions. J Clin Psychiatry 58 (1997) 32-49
43. Grabe H.J., Meyer C., Hapke U., Rumpf H.J., Freyberger H.J., Dilling H., et al. Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in Northern Germany. Eur Arch Psychiatry Clin Neurosci 251 (2001) 130-135
44. Hawkridge S., Stein D.J., and Bouwer C. Combining neuroleptics with serotonin specific reuptake inhibitors in Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 35 (1996) 703-704
45. Hoehn-Saric R., and Barksdale V.C. Impulsiveness in obsessive-compulsive patients. Br J Psychiatry 143 (1983) 177-182
46. Hollander E. Treatment of obsessive-compulsive spectrum disorders with SSRIs. Br J Psychiatry Suppl (1998) 7-12
47. Hollander E., and Phillips K. Body image and experiences disorders. In: American Psychiatric Press (Ed). Obsessive-compulsive related disorders (1993) 17-48 Washington, DC
48. Hollander E., and Rosen J. Impulsivity. J Psychopharmacol 14 (2000) S39-S44
49. Hollander E., Liebowitz M.R., Winchel R., Klumker A., and Klein D.F. Treatment of body dysmorphic disorder with serotonin reuptake blockers. Am J Psychiatry 146 (1989) 768-770
50. Hollander E., DeCaria C.M., Nitescu A., Gully R., Suckow R.F., Cooper T.B., et al. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 49 (1992) 21-28
51. Hollander E., Buchalter A.J., and DeCaria C.M. Pathological gambling. Psychiatr Clin North Am 23 (2000) 629-642
52. Holzer J.C., Goodman W.K., McDougle C.J., Baer L., Boyarsky B.K., Leckman J.F., et al. Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients. Br J Psychiatry 164 (1994) 469-473
53. Hudson J.I., and Pope H.G. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology?. Am J Psychiatry 147 (1990) 552-564
54. Insel T.R., and Akiskal H.S. Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis. Am J Psychiatry 143 (1986) 1527-1533
55. Insel T.R., Kalin N.H., Guttmacher L.B., Cohen R.M., and Murphy D.L. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder. Psychiatry Res 6 (1982) 153-160
56. Jaisoorya T.S., Reddy Y.C., and Srinath S. The relationship of obsessive-compulsive disorder to putative spectrum disorders: results from an Indian study. Compr Psychiatry 44 (2003) 317-323
57. Janet P. Les Obsessions et al Psychasthenie (1903), Alcan, Paris
58. Karayiorgou M., Altemus M., Galke B.L., Goldman D., Murphy D.L., Ott J., et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A 94 (1997) 4572-4575
59. Karayiorgou M., Sobin C., Blundell M.L., Galke B.L., Malinova L., Goldberg P., et al. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45 (1999) 1178-1189
60. Karno M., Golding J.M., Sorenson S.B., and Burnam M.A. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 45 (1988) 1094-1099
61. Kozak M.J., and Foa E.B. Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder. Behav Res Ther 32 (1994) 343-353
62. Leckman J.F., Grice D.E., Barr L.C., de Vries A.L., Martin C., Cohen D.J., et al. Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety 1 (1994) 208-215
63. Leckman J.F., Pauls D.L., Zhang H., Rosario-Campos M.C., Katsovich L., Kidd K.K., et al. Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet 116B (2003) 60-68
64. Lelliott P.T., Noshirvani H.F., Basoglu M., Marks I.M., and Monteiro W.O. Obsessive-compulsive beliefs and treatment outcome. Psychol Med 18 (1988) 697-702
65. Lenane M.C., Swedo S.E., Rapoport J.L., Leonard H., Sceery W., and Guroff J.J. Rates of obsessive compulsive disorder in first degree relatives of patients with trichotillomania: a research note. J Child Psychol Psychiatry 33 (1992) 925-933
66. Leonard H.L., and Swedo S.E. Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). Int J Neuropsychopharmacol 4 (2001) 191-198
67. Leonard H.L., Lenane M.C., Swedo S.E., Rettew D.C., and Rapoport J.L. A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting). Arch Gen Psychiatry 48 (1991) 821-827
68. Leonard H.L., Swedo S.E., Rapoport J.L., Rickler K.C., Topol D., Lee S., et al. Tourette syndrome and obsessive-compulsive disorder. Adv Neurol 58 (1992) 83-93
69. Lochner C., and Stein D.J. Heterogeneity of obsessive-compulsive disorder: a literature review. Harv Rev Psychiatr 11 (2003) 113-132
70. Lochner C., Hemmings S.M.J., Kinnear C.J., Niehaus D.J.H., Nel D.G., Corfield V.A., et al. Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates. Compr Psychiatry 46 (2005) 14-19
71. Mancini C., Van Ameringen M., and Farvolden P. Does SSRI augmentation with antidepressants that influence noradrenergivc function resolve depression in obsessive-compulsvie disorder?. J Affect Disord 68 (2002) 59-65
72. Marazziti D., Dell'Osso L., Di Nasso E., Pfanner C., Presta S., Mungai F., et al. Insight in obsessive-compulsive disorder: a study of an Italian sample. Eur Psychiatry 17 (2002) 407-410
73. Marks I.M. Fears, phobias and rituals: panic, anxiety and their disorders (1987), Oxford University Press, New York
74. Martin A.M., Scahill L., Vitulano L., and King R.A. Stimulant use and trichotillomania [letter]. J Am Acad Child Adolesc Psychiatry 37 (1998) 349-350
75. Matsunaga H., Kiriike N., Matsui T., Oya K., Iwasaki Y., Koshimune K., et al. Obsessive-compulsive disorder with poor insight. Compr Psychiatry 43 (2002) 150-157
76. McDougle C.J. The neurobiology and treatment of obsessive-compulsive disorder. In: Charney D.S., Nestler E.J., and Bunney B.S. (Eds). Neurobiology of Mental Illness (1999), Oxford University Press, New York 518-533
77. McDougle C.J., Goodman W.K., Leckman J.F., Lee N.C., Heninger G.R., and Price L.H. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 51 (1994) 302-308
78. McDougle C.J., Goodman W.K., and Price L.H. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry 55 (1994) 24-31 [Suppl]
79. McDougle C.J., Epperson C.N., Pelton G.H., Wasylink S., and Price L.H. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 57 (2000) 794-801
80. McElroy S.L., Phillips K.A., and Keck Jr. P.E. Obsessive compulsive spectrum disorders. J Clin Psychiatry 55 (1994) 33-51 [Suppl]
81. McElroy S.L., Arnold L.M., Shapira N.A., Keck Jr. P.E., Rosenthal N.R., Karim M.R., et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 160 (2003) 255-261
82. McKay D., Neziroglu F., and Yaryura-Tobias J.A. Comparison of clinical characteristics on obsessive-compulsive disorder. J Anxiety Disord 11 (1997) 447-454
83. Miguel E.C., Leckman J.F., Rauch S.L., do Rosario-Campos M.C., Hounie A.G., Mercadante M.T., et al. Obsessive-compulsive disorder phenotypes: Implications for genetic studies. Mol Psychiatry 10 (2005) 258-275
84. Modell J.G., Glaser F.B., Cyr L., and Mountz J.M. Obsessive and compulsive characteristics of craving for alcohol in alcohol abuse and dependence. Alcohol Clin Exp Res 16 (1992) 272-274
85. Modell J.G., Glaser F.B., Mountz J.M., Schmaltz S., and Cyr L. Obsessive and compulsive characteristics of alcohol abuse and dependence: quantification by a newly developed questionnaire. Alcohol Clin Exp Res 16 (1992) 266-271
86. Moriarty J., Eapen V., Costa D.C., Gacinovic S., Trimble M., Ell P.J., et al. HMPAO SPET does not distinguish obsessive-compulsive and tic syndromes in families multiply affected with Gilles de la Tourette's syndrome. Psychol Med 27 (1997) 737-740
87. Mundo E., Richter M.A., Sam F., Macciardi F., and Kennedy J.L. Is the 5-HT (1Dbeta) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder?. Am J Psychiatry 157 (2000) 1160-1161
88. Niehaus D.J., Emsley R.A., Brink P., and Stein D.J. Stereotypies: prevalence and association with compulsive and impulsive symptoms in college students. Psychopathology 33 (2000) 31-35
89. Okasha A., Saad A., Khalil A.H., el Dawla A.S., and Yehia N. Phenomenology of obsessive-compulsive disorder: a transcultural study. Compr Psychiatry 35 (1994) 191-197
90. Pato M.T., Pato C.N., and Pauls D.L. Recent findings in the genetics of OCD. J Clin Psychiatry 63 (2002) 30-33
91. Pauls D.L., Towbin K.E., Leckman J.F., Zahner G.E., and Cohen D.J. Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry 43 (1986) 1180-1182
92. Pauls D.L., Alsobrook J.P., Goodman W., Rasmussen S., and Leckman J.F. A family study of obsessive-compulsive disorder. Am J Psychiatry 152 (1995) 76-84
93. Phillips K.A. Body dysmorphic disorder: the distress of imagined ugliness. Am J Psychiatry 148 (1991) 1138-1149
94. Phillips K.A., and Najjar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry 64 (2003) 715-720
95. Phillips K.A., Dwight M.M., and McElroy S.L. Efficacy and safety of fluvoxamine in BDD. J Clin Psychiatry 59 (1988) 165-171
96. Phillips K.A., Gunderson C.G., Mallya G., McElroy S.L., and Carter W. A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. J Clin Psychiatry 59 (1998) 568-575
97. Phillips K.A., McElroy S.L., Dwight M.M., Eisen J.L., and Rasmussen S.A. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. J Clin Psychiatry 62 (2001) 87-91
98. Pigott T.A., and Seay S.M. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry 60 (1999) 101-106
99. Pigott T.A., L'Heureux F., Dubbert B., Bernstein S., and Murphy D.L. Obsessive compulsive disorder: comorbid conditions. J Clin Psychiatry 55 (1994) 15-27 [Suppl]
100. Pitman R.K., Green R.C., Jenike M.A., and Mesulam M.M. Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. Am J Psychiatry 144 (1987) 1166-1171
101. Rasmussen S.A., and Tsuang M.T. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry 143 (1986) 317-322
102. Rauch S.L. Neuroimaging research and the neurobiology of obsessive-compulsive disorder: where do we go from here?. Biol Psychiatry 47 (2000) 168-170
103. Rauch S.L., and Baxter L.R. Neuroimaging in obsessive-compulsive disorder and related disorders. In: Jenike M.A., Baer L., and Minichiello W.E. (Eds). Obsessive-compulsive disorders: practical management (1998), Mosby, St. Louis
104. Richter M.A., Summerfeldt L.J., Antony M.M., and Swinson R.P. Obsessive-compulsive spectrum conditions in obsessive-compulsive disorder and other anxiety disorders. Depress Anxiety 18 (2003) 118-127
105. Salzman L. Obsessional personality (1968), Science House, New York
106. Samuels J., Nestadt G., Bienvenu O.J., Costa Jr. P.T., Riddle M.A., and Liang K.Y. Personality disorders and normal personality dimensions in obsessive-compulsive disorder. Br J Psychiatry 177 (2000) 457-462
107. Saxena S., and Rauch S.L. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 23 (2000) 563-586
108. Saxena S., Brody A.L., Schwartz J.M., and Baxter L.R. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl (1998) 26-37
109. Schindler K.M., Richter M.A., Kennedy J.L., Pato M.T., and Pato C.N. Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am J Med Genet 96 (2000) 721-724
110. Seedat S., Kesler S., Niehaus D.J., and Stein D.J. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress Anxiety 11 (2000) 185-186
111. Shapira N.A., Goldsmith T.D., and McElroy S.L. Treatment of binge-eating disorder with topiramate: a clinical case series. J Clin Psychiatry 61 (2000) 368-372
112. Simeon D., Hollander E., Stein D.J., Cohen L., and Aronowitz B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am J Psychiatry 152 (1995) 1207-1209
113. Singer H.S., Hahn I.H., and Moran T.H. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 30 (1991) 558-562
114. Skodol A.E., and Oldham J.M. Phenomenology, differential diagnosis, and comorbidity of the obsessive-compulsive spectrum disorders. In: Oldham J.M., and EHAES (Eds). Impulsivity and compulsivity (1996), American Psychiatric Press, Washington, DC 1-36
115. Stein D.J. Advances in the neurobiology of obsessive-compulsive disorder. Implications for conceptualizing putative obsessive-compulsive and spectrum disorders. Psychiatr Clin North Am 23 (2000) 545-562
116. Stein D.J. Neurobiology of the obsessive-compulsive spectrum disorders. Biol Psychiatry 47 (2000) 296-304
117. Stein D.J., and Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psychiatry 53 (1992) 123-126
118. Stein D.J., and Hollander E. Impulsive aggression and obsessive-compulsive disorder. Psychiatr Annals 23 (1993) 389-395
119. Stein D.J., and Hollander E. The spectrum of obsessive-compulsive related disorders. In: Hollander E. (Ed). Obsessive-compulsive related disorders (1993), American Psychiatric Press, Washington, DC
120. Stein D.J., and Stone M.H. Essential papers on obsessive-compulsive disorders (1997), New York University Press, New York
121. Stein D.J., Hollander E., DeCaria C.M., Simeon D., Cohen L., and Aronowitz B. M-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures. Biol Psychiatry 40 (1996) 508-513
122. Stein D.J., Bouwer C., Hawkridge S., and Emsley R.A. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. J Clin Psychiatry 58 (1997) 119-122
123. Summerfeldt L.J., Huta L.J., and Swinson R.P. Personality and obsessive-compulsive disorder. In: Swinson R.P., Antony M.M., Rachman S., and Richter M.A. (Eds). Obsessive-compulsive disorder: theory, research and treatment (1998), Guilforf Press, New York
124. Swedo S.E., Leonard H.L., Rapoport J.L., Lenane M.C., Goldberger E.L., and Cheslow D.L. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 321 (1989) 497-501
125. Swedo S.E., Rapoport J.L., Leonard H.L., Schapiro M.B., Rapoport S.I., and Grady C.L. Regional cerebral glucose metabolism of women with trichotillomania. Arch Gen Psychiatry 48 (1991) 828-833
126. Swedo S.E., Leonard H.L., and Kiessling L.S. Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics 93 (1994) 323-326
127. Tekin S., and Cummings J.L. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 53 (2002) 647-654
128. Thomsen P.H., and Jensen J. Latent class analysis of organic aspects of obsessive-compulsive disorder in children and adolescents. Acta Psychiatr Scand 84 (1991) 391-395
129. Turksoy N., Tukel R., Ozdemir O., and Karali A. Comparison of clinical characteristics in good and poor insight obsessive-compulsive disorder. J Anxiety Disord 16 (2002) 413-423
130. Van Ameringen M., Mancini C., Oakman J.M., and Farvolden P. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord 56 (1999) 219-226
131. Van Ameringen M., Oakman J.M., Mancini C., and Farvolden P. Obsessive-compulsive spectrum disorders: from serotonin to dopamine and back again. In: Fineberg N., Marazziti D., and Stein D.J. (Eds). Obsessive-compulsive disorder: a practical guide (2001), Martin Dunitz Ltd, London 23-36
132. Volkow N.D., Wang G.-J., Hitzemann R., Fowler J.S., Overall J.E., Burr G., et al. Recovery of brain glucose metabolism in detoxified alcoholics. Am J Psychiatry 151 (1994) 178-183
133. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines (1992), World Health Organization, Geneva
134. Zella S.J., Geenens D.L., and Horst J.N. Repetitive eructation as a manifestation of obsessive-compulsive disorder. Psychosomatics 39 (1998) 299-301
135. Zohar J., and Insel T.R. Drug treatment of obsessive-compulsive disorder. J Affect Disord 13 (1987) 193-202
136. Zungu-Dirwayi N., Hugo F., van Heerden B.B., and Stein D.J. Are musical obsessions a temporal lobe phenomenon?. J Neuropsychiatry Clin Neurosci 11 (1999) 398-400